Nanjing Guangwei Medical Technology Co., Ltd.

To explore the optimal dosage of oral GW117 tablets for the treatment of depression, preliminarily evaluate the efficacy and safety, and provide a basis for the research design and dosing regimen of the Phase III clinical trial.

To study the tolerance and pharmacokinetics of a single oral administration of different doses of GW117 capsules in healthy subjects, to study the tolerance and pharmacokinetics of multiple oral administration of different doses of GW117 capsules in healthy subjects, and to study the effect of diet on the pharmacokinetics of oral GW117 capsules in healthy subjects, so as to provide a basis for later clinical trials.